Chequeo Menopausia

A menopause-focused health assessment combining gynaecologist and endocrinologist consultations with thyroid function testing, HbA1c, vitamin D measurement, bone density scanning (DEXA), bioimpedance body composition analysis, HPV screening, mammography, and breast ultrasound. Designed to address the interconnected hormonal, metabolic, and skeletal changes that accompany the menopausal transition.

The menopausal transition brings changes that extend well beyond reproductive hormone shifts, affecting bone density, cardiovascular risk, metabolic function, thyroid regulation, and body composition. This programme is structured to evaluate these interconnected domains through a combination of specialist consultations, targeted blood work, and imaging. Dual-consultant review by both a gynaecologist and an endocrinologist ensures that reproductive and metabolic aspects are assessed with appropriate specialist expertise. Thyroid function testing is included because thyroid disorders become more prevalent during and after menopause and may produce symptoms that overlap with menopausal complaints — fatigue, weight changes, mood disturbance, and temperature sensitivity. HbA1c provides a three-month average blood glucose reading, screening for the increased insulin resistance that commonly accompanies hormonal changes during this period. DEXA bone density scanning quantifies bone mineral density at key sites, establishing whether osteopenia or osteoporosis is present — a critical determination given the accelerated bone loss that occurs in the first five to ten years following menopause. Vitamin D measurement complements this assessment, as adequate vitamin D status is essential for calcium absorption and bone maintenance. Bioimpedance analysis provides body composition data including lean mass, fat mass, and hydration status. Breast screening through both mammography and ultrasound provides complementary imaging modalities — mammography excels at detecting calcifications while ultrasound is more sensitive for masses in dense breast tissue. HPV screening addresses cervical cancer risk. This programme brings together assessments that would typically require multiple specialist appointments over several weeks into a single coordinated visit at the JCI-accredited hospital.